However, the genetic alterations that give rise to uveal melanoma (i.e., GNAQ) differ from those in cutaneous melanoma (i.e., BRAF, CDKN2A, CDK4), suggesting that different pathways may be involved in their progression. Here, CDKN2A is linked to uveal melanoma.